Acadia Pharmaceuticals Q4 2025 Earnings Call

Acadia Pharmaceuticals' fourth quarter and full year 2025 earnings presentation delivered February 25, 2026. The call covers commercial updates on flagship products NUPLAZID and DAYBUE, R&D progress, and financial results for the fiscal year.